{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:02:33Z","timestamp":1792000953354,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12325-018-0680-6","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T04:53:49Z","timestamp":1520225629000},"page":"261-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"35","author":[{"given":"Hrvoje","family":"Bari\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veljko","family":"\u0110or\u0111evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cerove\u010dki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Trkulja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of dsm-iii-r psychiatric disorders in the united states. Results from the national comorbidity survey. Arch Gen Psychiatry. 1994;51:8\u201319.","journal-title":"Arch Gen Psychiatry"},{"key":"680_CR2","first-page":"42","volume":"68","author":"DJ Nutt","year":"2007","unstructured":"Nutt DJ, Kessler RC, Alonso J, et al. Consensus statement on the benefit to the community of ESEMeD (European study of the epidemiology of mental disorders) survey data on depression and anxiety. J Clin Psychiatry. 2007;68:42\u20138.","journal-title":"J Clin Psychiatry"},{"key":"680_CR3","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1176\/appi.ajp.161.12.2230","volume":"161","author":"M Stein","year":"2004","unstructured":"Stein M, Sherbourne C, Craske M, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry. 2004;161:2230\u20137.","journal-title":"Am J Psychiatry"},{"key":"680_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month dsm-iv disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"680_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0047.2004.00325.x","volume":"109","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer M, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109:21\u20137.","journal-title":"Acta Psychiatr Scand"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1177\/0269881107076996","volume":"21","author":"RB Hidalgo","year":"2007","unstructured":"Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol. 2007;21:864\u201372.","journal-title":"J Psychopharmacol"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/00048670903107575","volume":"43","author":"I Schweitzer","year":"2009","unstructured":"Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry. 2009;43:795\u2013808.","journal-title":"Aust N Z J Psychiatry"},{"key":"680_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S1461145705006358","volume":"10","author":"DS Baldwin","year":"2007","unstructured":"Baldwin DS, Montgomery SA, Nil R, et al. Discontinuation symptoms in depression and anxiety disorders. Int J Neuropsychopharmacol. 2007;10:73\u201384.","journal-title":"Int J Neuropsychopharmacol"},{"key":"680_CR9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0006-3223(02)01552-4","volume":"10","author":"EB Foa","year":"2002","unstructured":"Foa EB, Franklin ME, Moser J. Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination. Biol Psychiatry. 2002;10:987\u201397.","journal-title":"Biol Psychiatry"},{"key":"680_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S1461145704004870","volume":"8","author":"DS Baldwin","year":"2005","unstructured":"Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychoph. 2005;8:293\u2013302.","journal-title":"Int J Neuropsychoph"},{"key":"680_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/1570159X1304150831122734","volume":"13","author":"L Liu","year":"2015","unstructured":"Liu L, Liu C, Wang Y, et al. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol. 2015;13:481\u201393.","journal-title":"Curr Neuropharmacol"},{"key":"680_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/da.20460","volume":"26","author":"G Kinrys","year":"2009","unstructured":"Kinrys G, Coleman E, Rothstein E. Natural remedies for anxiety disorders: potential use and clinical applications. Depress Anxiety. 2009;26:259\u201365.","journal-title":"Depress Anxiety"},{"key":"680_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.phymed.2008.04.014","volume":"15","author":"P Garcia-Garcia","year":"2008","unstructured":"Garcia-Garcia P, Lopez-Munoz F, Rubio G, et al. Phytotherapy and psychiatry: bibliometric study of the scientific literature from the last 20 years. Phytomedicine. 2008;15:566\u201376.","journal-title":"Phytomedicine"},{"key":"680_CR14","unstructured":"Williams J, Gierisch J, McDuffie J, et al. An overview of complementary and alternative medicine therapies for anxiety and depressive disorders: supplement to efficacy of complementary and alternative medicine therapies for posttraumatic stress disorder. Evidence-based synthesis program. Washington: Department of Veterans Affairs; 2011:1\u201323."},{"key":"680_CR15","doi-asserted-by":"publisher","first-page":"809653","DOI":"10.1155\/2012\/809653","volume":"2012","author":"J Sarris","year":"2012","unstructured":"Sarris J, Moylan S, Camfield DA, et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evid Based Complement Alternat Med. 2012;2012:809653.","journal-title":"Evid Based Complement Alternat Med."},{"key":"680_CR16","first-page":"S29","volume":"181","author":"AF Jorm","year":"2004","unstructured":"Jorm AF, Christensen H, Griffiths KM, et al. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust. 2004;181:S29\u201346.","journal-title":"Med J Aust"},{"key":"680_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1359105310375635","volume":"16","author":"J Sarris","year":"2010","unstructured":"Sarris J, Goncalves D, Robins-Wahlins T, et al. Complementary medicine use by middle-aged and older women: personality, mood and anxiety factors. J Health Psychol. 2010;16:314\u201321.","journal-title":"J Health Psychol"},{"key":"680_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","volume":"280","author":"D Eisenberg","year":"1998","unstructured":"Eisenberg D, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey. JAMA. 1998;280:1569\u201375.","journal-title":"JAMA"},{"key":"680_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1176\/appi.ajp.157.11.1851","volume":"157","author":"J Unutzer","year":"2000","unstructured":"Unutzer J, Klap R, Sturm R, et al. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000;157:1851\u20137.","journal-title":"Am J Psychiatry"},{"key":"680_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1176\/appi.ajp.158.2.289","volume":"158","author":"R Kessler","year":"2001","unstructured":"Kessler R, Soukup J, Davis R, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158:289\u201394.","journal-title":"Am J Psychiatry"},{"key":"680_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1586\/14737175.2014.892420","volume":"14","author":"A Bazzan","year":"2014","unstructured":"Bazzan A, Zabrecky G, Monti D, et al. Current evidence regarding the management of mood and anxiety disorders using complementary and alternative medicine. Expert Rev Neurother. 2014;14:411\u201323.","journal-title":"Expert Rev Neurother"},{"key":"680_CR22","unstructured":"Generalised anxiety disorder and panic disorder in adults: management | Guidance and guidelines | NICE.\u00a0Niceorguk. 2017. Available at: https:\/\/www.nice.org.uk\/guidance\/cg113\/chapter\/1-Guidance#principles-of-care-for-people-with-generalised-anxiety-disorder-gad . Accessed April 25, 2017."},{"key":"680_CR23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"680_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF. The Hartung\u2013Knapp\u2013Sidik\u2013Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Method. 2014;14:25.","journal-title":"BMC Med Res Method"},{"key":"680_CR25","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","volume":"342","author":"R Riley","year":"2011","unstructured":"Riley R, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.","journal-title":"BMJ"},{"key":"680_CR26","first-page":"7","volume":"1","author":"AGH Kessels","year":"2013","unstructured":"Kessels AGH, terRiet G, Puhan MA, et al. A simple regression model for network meta-analysis. OA Epidemol. 2013;1:7.","journal-title":"OA Epidemol"},{"key":"680_CR27","doi-asserted-by":"crossref","unstructured":"Brown H, Prescott R. Applied mixed models in medicine, 3rd ed, Wiley 2013:197-230.","DOI":"10.1002\/9781118778210"},{"key":"680_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/0470854200","volume-title":"Meta-analysis of controlled clinical trials","author":"A Whitehead","year":"2002","unstructured":"Whitehead A. Meta-analysis of controlled clinical trials. New Jersey: Wiley; 2002. p. 131\u20136."},{"key":"680_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-979474","volume":"30","author":"H Volz","year":"1997","unstructured":"Volz H, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders\u2014a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1\u20135.","journal-title":"Pharmacopsychiatry."},{"key":"680_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s002130100792","volume":"157","author":"U Malsch","year":"2001","unstructured":"Malsch U, Kieser M. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology. 2001;157:277\u201383.","journal-title":"Psychopharmacology"},{"key":"680_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00004850-200207000-00005","volume":"17","author":"K Connor","year":"2002","unstructured":"Connor K, Davidson J. A placebo-controlled study of Kava kava in generalized anxiety disorder. Int Clin Psychopharmacol. 2002;17:185\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"680_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/JCP.0b013e318291be67","volume":"33","author":"J Sarris","year":"2013","unstructured":"Sarris J, Stough C, Bousman C, et al. Kava in the treatment of generalized anxiety disorder. J Clin Psychopharmacol. 2013;33:643\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"680_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1185\/135525701317094340","volume":"7","author":"D Wheatley","year":"2001","unstructured":"Wheatley D. Kava-kava (LI 150) in the treatment of generalized anxiety disorder. Primary Care Psychia. 2001;7:97\u2013100.","journal-title":"Primary Care Psychia"},{"key":"680_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1078\/1433-187X-00309","volume":"10","author":"R Boerner","year":"2003","unstructured":"Boerner R, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M. Kava-Kava extract LI 150 is as effective as opipramol and buspirone in generalised anxiety disorder\u2014an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine. 2003;10:38\u201349.","journal-title":"Phytomedicine"},{"key":"680_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.phymed.2009.10.006","volume":"17","author":"H Woelk","year":"2010","unstructured":"Woelk H, Schl\u00e4fke S. A multi-center, double-blind, randomized study of the Lavender oil preparation Silexan in comparison to lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17:94\u20139.","journal-title":"Phytomedicine"},{"key":"680_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1017\/S1461145714000017","volume":"17","author":"S Kasper","year":"2014","unstructured":"Kasper S, Gastpar M, M\u00fcller W, et al. Lavender oil preparation Silexan is effective in generalized anxiety disorder\u2014a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol. 2014;17:859\u201369.","journal-title":"Int J Neuropsychopharmacol"},{"key":"680_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1055\/s-2007-981539","volume":"73","author":"A Herrera-Arellano","year":"2007","unstructured":"Herrera-Arellano A, Jim\u00e9nez-Ferrer E, Zamilpa A, Morales-Vald\u00e9z M, Garc\u00eda-Valencia C, Tortoriello J. Efficacy and tolerability of a standardized herbal product from Galphimiaglauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with Lorazepam. Planta Med. 2007;73:713\u20137.","journal-title":"Planta Med"},{"key":"680_CR38","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1055\/s-0032-1315110","volume":"78","author":"A Herrera-Arellano","year":"2012","unstructured":"Herrera-Arellano A, Jim\u00e9nez-Ferrer J, Zamilpa A, Garc\u00eda-Alonso G, Herrera-Alvarez S, Tortoriello J. Therapeutic effectiveness of Galphimiaglauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial. Planta Med. 2012;78:1529\u201335.","journal-title":"Planta Med"},{"key":"680_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/JCP.0b013e3181ac935c","volume":"29","author":"J Amsterdam","year":"2009","unstructured":"Amsterdam J, Li Y, Soeller I, Rockwell K, Mao J, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (Chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29:378\u201382.","journal-title":"J Clin Psychopharmacol"},{"key":"680_CR40","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.phymed.2016.10.012","volume":"23","author":"J Mao","year":"2016","unstructured":"Mao J, Xie S, Keefe J, Soeller I, Li Q, Amsterdam J. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial. Phytomedicine. 2016;23:1735\u201342.","journal-title":"Phytomedicine"},{"key":"680_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/030079903125002603","volume":"20","author":"M Hanus","year":"2004","unstructured":"Hanus M, Lafon J, Mathieu M. Double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin. 2004;20:63\u201371.","journal-title":"Curr Med Res Opin"},{"key":"680_CR42","first-page":"697","volume":"11","author":"M Sayyah","year":"2012","unstructured":"Sayyah M, Siahpoosh A, Khalili H, Malayeri A, Samaee H. A double-blind, placebo-controlled study of the aqueous extract of Echium amoenum for patients with general anxiety disorder. Iran J Pharm Res. 2012;11:697\u2013701.","journal-title":"Iran J Pharm Res."},{"key":"680_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jep.2014.10.024","volume":"158","author":"D Park","year":"2014","unstructured":"Park D, Kim S, Park Y, Kang W, Lee S, Jung I. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: Multicenter, randomized, double blind, placebo controlled trial. J Ethnopharmacol. 2014;158:11\u20137.","journal-title":"J Ethnopharmacol"},{"key":"680_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2710.2001.00367.x","volume":"26","author":"S Akhondzadeh","year":"2001","unstructured":"Akhondzadeh S, Naghavi H, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26:363\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"680_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ptr.1027","volume":"16","author":"R Andreatini","year":"2002","unstructured":"Andreatini R, Sartori V, Seabra M, Leite J. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res. 2002;16:650\u20134.","journal-title":"Phytother Res"},{"key":"680_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S1995-7645(12)60150-3","volume":"5","author":"T Wang","year":"2012","unstructured":"Wang T, Ding J, Xu G, Zeng Y, Xiao S. Efficacy of Yiqiyangxin Chinese medicine compound combined with cognitive therapy in the treatment of generalized anxiety disorders. Asian Pac J Trop Med. 2012;5:818\u201322.","journal-title":"Asian Pac J Trop Med"},{"key":"680_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2000-11624","volume":"68","author":"H Eich","year":"2000","unstructured":"Eich H, Agelink M, Lehmann E, Lemmer W, Klieser E. AkupunkturbeileichtenbismittelschwerendepressivenEpisoden und Angstst\u00f6rungen\u2013Ergebnisseeiner experimentellen Untersuchung. Fortschr Neurol Psychiatr. 2000;68:137\u201344.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"680_CR48","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.janxdis.2007.09.010","volume":"22","author":"D Merom","year":"2008","unstructured":"Merom D, Phongsavan P, Wagner R, et al. Promoting walking as an adjunct intervention to group cognitive behavioral therapy for anxiety disorders\u2014 a pilot group randomized trial. J Anxiety Disord. 2008;22:959\u201368.","journal-title":"J Anxiety Disord"},{"key":"680_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctim.2009.11.003","volume":"18","author":"O Dubois","year":"2010","unstructured":"Dubois O, Salamon R, Germain C, et al. Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder. Complement Ther Med. 2010;18:1\u20137.","journal-title":"Complement Ther Med."},{"key":"680_CR50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/da.20671","volume":"27","author":"K Sherman","year":"2010","unstructured":"Sherman K, Ludman E, Cook A, et al. Effectiveness of therapeutic massage for generalized anxiety disorder: a randomized controlled trial. Depress Anxiety. 2010;27:441\u201350.","journal-title":"Depress Anxiety"},{"key":"680_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000327898","volume":"81","author":"M Herring","year":"2012","unstructured":"Herring M, Jacob M, Suveg C, Dishman R, O\u2019Connor P. Feasibility of exercise training for the short-term treatment of generalized anxiety disorder: a randomized controlled trial. Psychother Psychosom. 2012;81:21\u20138.","journal-title":"Psychother Psychosom"},{"key":"680_CR52","doi-asserted-by":"crossref","unstructured":"Ma H, Kui Y, Li Y, Huang B, Li S, Chen X. Bloodletting therapy combined with paroxetine hydrochloride for generalized anxiety disorder: A randomized controlled trial. 2013 IEEE International Conference on Bioinformatics and Biomedicine. 2013.","DOI":"10.1109\/BIBM.2013.6732667"},{"key":"680_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12906-016-1089-x","volume":"16","author":"K Jonsson","year":"2016","unstructured":"Jonsson K, Kjellgren A. Promising effects of treatment with flotation-REST (restricted environmental stimulation technique) as an intervention for generalized anxiety disorder (GAD): a randomized controlled pilot trial. BMC Complement Altern Med. 2016;16:108.","journal-title":"BMC Complement Altern Med"},{"key":"680_CR54","doi-asserted-by":"crossref","unstructured":"Rapaport M, Schettler P, Larson E et al. Acute Swedish massage monotherapy successfully remediates symptoms of generalized anxiety disorder. J Clin Psychiatry 2016:e883\u2013e891.","DOI":"10.4088\/JCP.15m10151"},{"key":"680_CR55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4088\/JCP.v64n0309","volume":"64","author":"O Bonne","year":"2003","unstructured":"Bonne O, Shemer Y, Gorali Y, Katz M, Shalev A. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. J Clin Psychiatry. 2003;64:282\u20137.","journal-title":"J Clin Psychiatry"},{"key":"680_CR56","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/acm.2010.0778","volume":"18","author":"B Tubaki","year":"2012","unstructured":"Tubaki B, Chandrashekar C, Sudhakar D, Prabha T, Lavekar G, Kutty B. Clinical efficacy of Manasamitra Vataka (an ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study. J Altern Complement Med. 2012;18:612\u201321.","journal-title":"J Altern Complement Med"},{"key":"680_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/0973-8258.142677","volume":"8","author":"K Gupta","year":"2014","unstructured":"Gupta K, Mamidi P, Thakar A. Randomized placebo controlled study on Sarasvata choorna in generalised anxiety disorder. Int J Green Pharm. 2014;8:231\u20136.","journal-title":"Int J Green Pharm"},{"key":"680_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/136346150203900105","volume":"39","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Young D, Lee S, et al. Chinese Taoist cognitive psychotherapy in the treatment of generalized anxiety disorder in contemporary China. Transcult Psychiatry. 2002;39:115\u201329.","journal-title":"Transcult Psychiatry"},{"key":"680_CR59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jclp.20663","volume":"66","author":"D Koszycki","year":"2010","unstructured":"Koszycki D, Raab K, Aldosary F, Bradwejn J. A multifaith spiritually based intervention for generalized anxiety disorder: a pilot randomized trial. J Clin Psychol. 2010;66:430\u201341.","journal-title":"J Clin Psychol"},{"key":"680_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jclp.22052","volume":"70","author":"D Koszycki","year":"2013","unstructured":"Koszycki D, Bilodeau C, Raab-Mayo K, Bradwejn J. A multifaith spiritually based intervention versus supportive therapy for generalized anxiety disorder: a pilot randomized controlled Trial. J Clin Psychol. 2013;70:489\u2013509.","journal-title":"J Clin Psychol"},{"key":"680_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/15622970209150621","volume":"3","author":"B Bandelow","year":"2002","unstructured":"Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002;3:171\u201399.","journal-title":"World J Biol Psychiatry"},{"key":"680_CR62","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/070674371205700805","volume":"57","author":"BG Bereza","year":"2012","unstructured":"Bereza BG, Machado M, Ravindran AV, Einarson TR. Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder. Can J Psychiatry. 2012;57:470\u20138.","journal-title":"Can J Psychiatry"},{"key":"680_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0269881114525674","volume":"28","author":"D Baldwin","year":"2014","unstructured":"Baldwin D, Anderson I, Nutt D, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28:403\u201339.","journal-title":"J Psychopharmacol"},{"key":"680_CR64","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40261-017-0528-x","volume":"37","author":"M Mochcovitch","year":"2017","unstructured":"Mochcovitch M, da Rocha Freire R, Garcia R, Nardi A. Can long-term pharmacotherapy prevent relapses in generalized anxiety disorder? A Systematic Review. Clin Drug Investig. 2017;37:737\u201343.","journal-title":"A Systematic Review. Clin Drug Investig"},{"key":"680_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/15622970601110273","volume":"8","author":"B Bandelow","year":"2007","unstructured":"Bandelow B, Seidler-Brandler U, Becker A, Wedekind D, R\u00fcther E. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry. 2007;8:175\u201387.","journal-title":"World J Biol Psychiatry"},{"key":"680_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","volume":"30","author":"B Bandelow","year":"2015","unstructured":"Bandelow B, Reitt M, R\u00f6ver C, Michaelis S, G\u00f6rlich Y, Wedekind D. Efficacy of treatments for anxiety disorders. Int Clin Psychopharmacol. 2015;30:183\u201392.","journal-title":"Int Clin Psychopharmacol"},{"key":"680_CR67","first-page":"572","volume":"27","author":"MW Otto","year":"2005","unstructured":"Otto MW, Smits JA, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psychol Sci Pract. 2005;27:572\u201381.","journal-title":"Clin Psychol Sci Pract"},{"key":"680_CR68","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-135-4-200108210-00011","volume":"135","author":"RC Kessler","year":"2001","unstructured":"Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001;135:262\u20138.","journal-title":"Ann Intern Med"},{"key":"680_CR69","doi-asserted-by":"crossref","unstructured":"Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007, National health statistics reports; no 12.Hyattsville, MD: National Center for Health Statistics; 2008.","DOI":"10.1037\/e623942009-001"},{"key":"680_CR70","doi-asserted-by":"crossref","unstructured":"Fontenelle L, Santana. A review of studies concerning treatment adherence of patients with anxiety disorders. Patient Prefer Adherence. 2011;5:427\u201339.","DOI":"10.2147\/PPA.S23439"},{"key":"680_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/000271620258300103","volume":"583","author":"WB Jonas","year":"2002","unstructured":"Jonas WB. Policy, the public, and priorities in alternative medicine research. Ann Am Acad Polit Soc Sci. 2002;583:29\u201343.","journal-title":"Ann Am Acad Polit Soc Sci"},{"key":"680_CR72","unstructured":"Complementary and alternative medicine in the United States. 1st ed. Washington, DC: The National Academies Press; 2005."},{"key":"680_CR73","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ptr.4916","volume":"27","author":"J Sarris","year":"2013","unstructured":"Sarris J, Stough C, Teschke R, et al. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects. Phytother Res. 2013;27:1723\u20138.","journal-title":"Phytother Res"},{"key":"680_CR74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5694\/j.1326-5377.2006.tb00557.x","volume":"185","author":"AC Plint","year":"2006","unstructured":"Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust. 2006;185:263\u20137.","journal-title":"Med J Aust"},{"key":"680_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0269881108091068","volume":"22","author":"D Nutt","year":"2008","unstructured":"Nutt D, Allgulander C, Lecrubier Y, Peters T, Wittchen H. Establishing non-inferiority in treatment trials in psychiatry\u2014guidelines from an Expert Consensus Meeting. J Psychopharmacol. 2008;22:409\u201316.","journal-title":"J Psychopharmacol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-018-0680-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0680-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0680-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:00:01Z","timestamp":1719846001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-018-0680-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0680-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}